Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485393 · ClinicalTrials.gov registry record · NA
Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01485393: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01485393 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01485393, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether dexmedetomidine can be used to induce normal physiological sleep in humans.
Interventions
- DRUG Dexmedetomidine
- DRUG Zolpidem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01485393
The ClinicalTrials.gov registry entry for NCT01485393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT01485393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01485393 about?
NCT01485393 is a clinical study titled "Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep". The purpose of this study is to determine whether dexmedetomidine can be used to induce normal physiological sleep in humans.
What is the current status of trial NCT01485393?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-01. Estimated completion is 2018-06-29.
What interventions are being tested in trial NCT01485393?
The interventions under investigation include: Dexmedetomidine (DRUG), Zolpidem (DRUG).
Who is sponsoring clinical trial NCT01485393?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.